World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane Biopharma och Episurf bjuder in till bolagspresentation den 29 maj i Stockholm
Read more >> -
Xbrane Biopharma and Episurf invites to a company presentation in Stockholm May 29
Read more >> -
Xbrane Biopharma publicerar kvartalsrapport för januari - mars 2018
Read more >> -
Xbrane Biopharma releases interim report for the first quarter of 2018
Read more >> -
Xbrane Biopharma publicerar Årsredovisning för 2017
Read more >>
X
